Madame Bioscience Public Company Limited
Madame Bioscience Public Company Limited, together with its subsidiaries, manufactures and sells plastic packaging in Thailand. The company operates through three segments: Packaging business; Food business; and Other business. It offers various food products, including frozen and chilled, plant based, hemp, sauce, dried fruit, and processed foods products under the Kitchen plus, Viiva, and LookC… Read more
Madame Bioscience Public Company Limited (MADAME) - Total Liabilities
Latest total liabilities as of September 2025: ฿878.26 Million THB
Based on the latest financial reports, Madame Bioscience Public Company Limited (MADAME) has total liabilities worth ฿878.26 Million THB as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Madame Bioscience Public Company Limited - Total Liabilities Trend (2021–2024)
This chart illustrates how Madame Bioscience Public Company Limited's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Madame Bioscience Public Company Limited Competitors by Total Liabilities
The table below lists competitors of Madame Bioscience Public Company Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Brouwerij Handelsmaatschappij NV
BR:COBH
|
Belgium | €68.08 Million |
|
Daekyo Co Ltd
KO:019685
|
Korea | ₩297.83 Billion |
|
National Capital Bank of Washington
PINK:NACB
|
USA | $639.32 Million |
|
Lapidoth
TA:LAPD
|
Israel | ILA5.00 Billion |
|
Lohakit Metal Public Company Limited
BK:LHK
|
Thailand | ฿425.43 Million |
|
Ihlas Yayin Holding A.S.
IS:IHYAY
|
Turkey | TL2.77 Billion |
|
Jeil M&S Co., Ltd
KQ:412540
|
Korea | ₩507.00 Billion |
|
Samwon Steel
KO:023000
|
Korea | ₩57.80 Billion |
Liability Composition Analysis (2021–2024)
This chart breaks down Madame Bioscience Public Company Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.98 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.99 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.49 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Madame Bioscience Public Company Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Madame Bioscience Public Company Limited (2021–2024)
The table below shows the annual total liabilities of Madame Bioscience Public Company Limited from 2021 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ฿1.08 Billion | -14.65% |
| 2023-12-31 | ฿1.26 Billion | -0.33% |
| 2022-12-31 | ฿1.27 Billion | +81.10% |
| 2021-12-31 | ฿698.73 Million | -- |